Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY: RMD )

236.53 +22.09 (+10.30%)
Streaming Delayed Price Updated: 3:58 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,780,090
Open 233.19
Bid (Size) 236.49 (6)
Ask (Size) 236.58 (2)
Prev. Close 214.44
Today's Range 227.40 - 239.66
52wk Range 179.00 - 263.05
Shares Outstanding 146,234,244
Dividend Yield 0.90%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast
ResMed posted Q3 EPS of $2.37 on $1.29 billion in sales, citing strong global demand for sleep devices, plus a boost from tariff exemptions. 
Via Benzinga
Topics World Trade
Exposures Tariff
What's going on in today's session: S&P500 movers
Get insights into the S&P500 index performance on Thursday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill

Performance

YTD
+3.53%
+3.53%
1 Month
+6.11%
+6.11%
3 Month
-4.36%
-4.36%
6 Month
-0.36%
-0.36%
1 Year
+28.40%
+28.40%

More News

Read More
Tesla To $450? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
These S&P500 stocks are gapping in today's session
Via Chartmill
Earnings Scheduled For April 23, 2025
Via Benzinga
Wall Street Rally Extends Into Third Day: What's Driving Markets Thursday?
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
Texas Instruments Posts Better-Than-Expected Results, Joins Community Health Systems, Hasbro, ServiceNow, ResMed And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Resmed Stock Rises Pre-Market On Upbeat Earnings, CEO Dismisses Tariff Impact: Retail Is Bullish
Via Stocktwits
Topics Earnings Economy Government
Exposures Financial Political Supply Chain
Which S&P500 stocks are moving after the closing bell on Wednesday?
Via Chartmill
ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With Expectations
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025
From Resmed, Inc.
Via GlobeNewswire
A Look Ahead: ResMed's Earnings Forecast
Via Benzinga
Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Stocks Surge On China Tariff Hopes, Tesla Jumps, Gold Loses Shine: What's Driving Markets Wednesday?
Via Benzinga
Topics Government
Exposures Political
Resmed Names Salli Schwartz as Chief Investor Relations Officer
From Resmed, Inc.
Via GlobeNewswire
Assessing ResMed: Insights From 5 Financial Analysts
Via Benzinga
Why RESMED INC (NYSE:RMD) is a Top Pick for Dividend Investors.
Via Chartmill
Which S&P500 stocks are gapping on Tuesday?
Via Chartmill
Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US
From Resmed, Inc.
Via GlobeNewswire
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025
From Resmed, Inc.
Via GlobeNewswire
Why RESMED INC (NYSE:RMD) Deserves Consideration as a Quality Investment.
Via Chartmill
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer
From Resmed, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.